FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Bohdan Wasylyk

Research Profile

Chemicals & Drugs

Physiology

Co-author Network

Publications

TOP 3
Jan Brants; Annaïck Carles; Jan de Mey; Olivier Poch; Karine Pradeau-Aubreton; Aude Robert; Jack A Schalken; Kostyantyn Semenchenko; Christine Wasylyk; Alberto Zambrano; Catherine Birck; Bohdan Wasylyk
Tubulin tyrosine ligase like 12, a TTLL family member with SET- and TTL-like domains and roles in histone and tubulin modifications and mitosis.
Juan Chen; Wei-Liang Sun; Yan-Ping Wang; Bohdan Wasylyk; Hong Zheng
c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells.
Christine Wasylyk; Alberto Zambrano; Chunhua Zhao; Jan Brants; Joseph Abecassis; Jack A Schalken; Hermann Rogatsch; Georg Schaefer; Armin Pycha; Helmut Klocker; Bohdan Wasylyk
Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Bohdan Wasylyk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Jan Brants; Annaïck Carles; Jan de Mey; Olivier Poch; Karine Pradeau-Aubreton; Aude Robert; Jack A Schalken; Kostyantyn Semenchenko; Christine Wasylyk; Alberto Zambrano; Catherine Birck; Bohdan Wasylyk
Tubulin tyrosine ligase like 12, a TTLL family member with SET- and TTL-like domains and roles in histone and tubulin modifications and mitosis.
PloS one 2012;7(12):e51258.
2012: Juan Chen; Wei-Liang Sun; Yan-Ping Wang; Bohdan Wasylyk; Hong Zheng
c-Jun N-terminal kinase mediates microtubule-depolymerizing agent-induced microtubule depolymerization and G2/M arrest in MCF-7 breast cancer cells.
Anti-cancer drugs 2012;23(1):98-107.
2010: Christine Wasylyk; Alberto Zambrano; Chunhua Zhao; Jan Brants; Joseph Abecassis; Jack A Schalken; Hermann Rogatsch; Georg Schaefer; Armin Pycha; Helmut Klocker; Bohdan Wasylyk
Tubulin tyrosine ligase like 12 links to prostate cancer through tubulin posttranslational modification and chromosome ploidy.
International journal of cancer. Journal international du cancer 2010;127(11):2542-53.
2010: C Ayoub; Christine Wasylyk; Y Li; E Thomas; L Marisa; A Robé; M Roux; Joseph Abecassis; A de Reyniès; Bohdan Wasylyk
ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines.
British journal of cancer 2010;103(5):715-26.
2010: Patrick Costello; Robert Nicolas; Jane Willoughby; Bohdan Wasylyk; Alfred Nordheim; Richard Treisman
Ternary complex factors SAP-1 and Elk-1, but not net, are functionally equivalent in thymocyte development.
Journal of immunology (Baltimore, Md. : 1950) 2010;185(2):1082-92.
2010: Tsvetan Serchov; Helene Dubois-Pot-Schneider; Celine Charlot; Frank Rösl; Bohdan Wasylyk
Involvement of net and Hif1alpha in distinct yet intricately linked hypoxia-induced signaling pathways.
The Journal of biological chemistry 2010;285(28):21223-32.
2010: Niall Kerr; Alexander Pintzas; Fiona Holmes; Sally-Ann Hobson; Robert Pope; Mark Wallace; Christine Wasylyk; Bohdan Wasylyk; David Wynick
The expression of ELK transcription factors in adult DRG: Novel isoforms, antisense transcripts and upregulation by nerve damage.
Molecular and cellular neurosciences 2010;44(2):165-77.
2010: Céline Charlot; Hélène Dubois-Pot; Tsvetan Serchov; Yves Tourrette; Bohdan Wasylyk
A review of post-translational modifications and subcellular localization of Ets transcription factors: possible connection with cancer and involvement in the hypoxic response.
Methods in molecular biology (Clifton, N.J.) 2010;647():3-30.
2010: Katrin Hacke; Bladimiro Rincon-Orozco; Gilles Buchwalter; Simone Y Siehler; Bohdan Wasylyk; Lisa Wiesmüller; Frank Rösl
Regulation of MCP-1 chemokine transcription by p53.
Molecular cancer 2010;9():82.
2009: Koji Nakade; Jianzhi Pan; Takahito Yamasaki; Takehide Murata; Bohdan Wasylyk; Kazunari K Yokoyama
JDP2 (Jun Dimerization Protein 2)-deficient mouse embryonic fibroblasts are resistant to replicative senescence.
The Journal of biological chemistry 2009;284(16):10808-17.
2008: Christine Wasylyk; Hong Zheng; Christelle Castell; Laurent Debussche; Marie-Christine Multon; Bohdan Wasylyk
Inhibition of the Ras-Net (Elk-3) pathway by a novel pyrazole that affects microtubules.
Cancer research 2008;68(5):1275-83.
2008: C Gross; H Dubois-Pot; Bohdan Wasylyk
The ternary complex factor Net/Elk-3 participates in the transcriptional response to hypoxia and regulates HIF-1 alpha.
Oncogene 2008;27(9):1333-41.
2007: Matthias Hebben; Jan Brants; Catherine Birck; Jean-Pierre Samama; Bohdan Wasylyk; Danièle Spehner; Karine Pradeau; Arban Domi; Bernard Moss; Patrick Schultz; Robert Drillien
High level protein expression in mammalian cells using a safe viral vector: modified vaccinia virus Ankara.
Protein expression and purification 2007;56(2):269-78.
2007: Christian Gross; Gilles Buchwalter; Hélène Dubois-Pot; Emilie Cler; Hong Zheng; Bohdan Wasylyk
The ternary complex factor net is downregulated by hypoxia and regulates hypoxia-responsive genes.
Molecular and cellular biology 2007;27(11):4133-41.
2007: Nicolas Wicker; Annaïck Carles; Ian Mills; Maija Wolf; Abhi Veerakumarasivam; Henrik Edgren; Fabrice Boileau; Bohdan Wasylyk; Jack A Schalken; David E Neal; Olli Kallioniemi; Olivier Poch
A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH.
BMC genomics 2007;8():84.
2006: Danièle Muller; Régine Millon; S Théobald; Thomas Hussenet; Bohdan Wasylyk; Stanislas du Manoir; Joseph Abecassis
Cyclin L1 (CCNL1) gene alterations in human head and neck squamous cell carcinoma.
British journal of cancer 2006;94(7):1041-4.
2006: Ira Kogan; Naomi Goldfinger; Michael Milyavsky; Merav Cohen; Igor Shats; Gabriele Dobler; Helmut Klocker; Bohdan Wasylyk; Maureen Voller; Tilly Aalders; Jack A Schalken; Moshe Oren; Varda Rotter
hTERT-immortalized prostate epithelial and stromal-derived cells: an authentic in vitro model for differentiation and carcinogenesis.
Cancer research 2006;66(7):3531-40.
2006: Annaïck Carles; Régine Millon; Anne Cromer; Gitali Ganguli; Frédéric Lemaire; Julia Young; Christine Wasylyk; Danièle Muller; I Schultz; Y Rabouel; Doulaye Dembélé; C Zhao; Patricia Marchal; C Ducray; L Bracco; Joseph Abecassis; Olivier Poch; Bohdan Wasylyk
Head and neck squamous cell carcinoma transcriptome analysis by comprehensive validated differential display.
Oncogene 2006;25(12):1821-31.
2006: Atefeh Seghatoleslam; Alberto Zambrano; Régine Millon; Gitali Ganguli; Manuela Argentini; Anne Cromer; Joseph Abecassis; Bohdan Wasylyk
Analysis of a novel human gene, LOC92912, over-expressed in hypopharyngeal tumours.
Biochemical and biophysical research communications 2006;339(1):422-9.
2005: Gilles Buchwalter; Christian Gross; Bohdan Wasylyk
The ternary complex factor Net regulates cell migration through inhibition of PAI-1 expression.
Molecular and cellular biology 2005;25(24):10853-62.
2005: Jan van Riggelen; Gilles Buchwalter; Ubaldo Soto; Johanna De-Castro Arce; Harald zur Hausen; Bohdan Wasylyk; Frank Rösl
Loss of net as repressor leads to constitutive increased c-fos transcription in cervical cancer cells.
The Journal of biological chemistry 2005;280(5):3286-94.
2005: Christine Wasylyk; Paola Criqui-Filipe; Bohdan Wasylyk
Sumoylation of the net inhibitory domain (NID) is stimulated by PIAS1 and has a negative effect on the transcriptional activity of Net.
Oncogene 2005;24(5):820-8.
2004: Frédéric Lemaire; Régine Millon; Danièle Muller; Y Rabouel; L Bracco; Joseph Abecassis; Bohdan Wasylyk
Loss of HOP tumour suppressor expression in head and neck squamous cell carcinoma.
British journal of cancer 2004;91(2):258-61.
2004: Sagar Sengupta; Bohdan Wasylyk
Physiological and pathological consequences of the interactions of the p53 tumor suppressor with the glucocorticoid, androgen, and estrogen receptors.
Annals of the New York Academy of Sciences 2004;1024():54-71.
2004: Anne Cromer; Annaïck Carles; Régine Millon; Gitali Ganguli; Frédéric Chalmel; Frédéric Lemaire; Julia Young; Doulaye Dembélé; Christelle Thibault; Danièle Muller; Olivier Poch; Joseph Abecassis; Bohdan Wasylyk
Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis.
Oncogene 2004;23(14):2484-98.
2004: Giusy Fiucci; Séverine Beaucourt; Dominique Duflaut; alexandra lespagnol; Pamela Stumptner-Cuvelette; Anne Géant; Gilles Buchwalter; Marcel Tuynder; Laurent Susini; Jean-Michel Lassalle; Christine Wasylyk; Bohdan Wasylyk; Moshe Oren; Robert Amson; Adam Telerman
Siah-1b is a direct transcriptional target of p53: identification of the functional p53 responsive element in the siah-1b promoter.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(10):3510-5.
2004: Koji Nakade; Hong Zheng; Gitali Ganguli; Gilles Buchwalter; Christian Gross; Bohdan Wasylyk
The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling.
Molecular and cellular biology 2004;24(3):1132-42.
2004: Gilles Buchwalter; Christian Gross; Bohdan Wasylyk
Ets ternary complex transcription factors.
Gene 2004;324():1-14.
2003: Gitali Ganguli; Bohdan Wasylyk
p53-independent functions of MDM2.
Molecular cancer research : MCR 2003;1(14):1027-35.
2003: Frédéric Lemaire; Régine Millon; Julia Young; Anne Cromer; Christine Wasylyk; I Schultz; Danièle Muller; Patricia Marchal; C Zhao; D Melle; L Bracco; Joseph Abecassis; Bohdan Wasylyk
Differential expression profiling of head and neck squamous cell carcinoma (HNSCC).
British journal of cancer 2003;89(10):1940-9.
2003: Hong Zheng; Christine Wasylyk; Abdelkader Ayadi; Joseph Abecassis; Jack A Schalken; Hermann Rogatsch; Nicolas Wernert; Sauveur-Michel Maira; Marie-Christine Multon; Bohdan Wasylyk
The transcription factor Net regulates the angiogenic switch.
Genes & development 2003;17(18):2283-97.
2003: Sagar Sengupta; Steven P Linke; Remy Pedeux; Qin Yang; Julie Farnsworth; Susan H Garfield; Kristoffer Valerie; Jerry W Shay; Nathan Ellis; Bohdan Wasylyk; Curtis C Harris
BLM helicase-dependent transport of p53 to sites of stalled DNA replication forks modulates homologous recombination.
The EMBO journal 2003;22(5):1210-22.
2002: Sophie DELTOUR; Sébastien Pinte; Cateline Guerardel; Bohdan Wasylyk; Dominique Leprince
The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif.
Molecular and cellular biology 2002;22(13):4890-901.
2002: Gitali Ganguli; Jonathan Back; Sagar Sengupta; Bohdan Wasylyk
The p53 tumour suppressor inhibits glucocorticoid-induced proliferation of erythroid progenitors.
EMBO reports 2002;3(6):569-74.
2002: Christine Wasylyk; Sophie E Schlumberger; Paola Criqui-Filipe; Bohdan Wasylyk
Sp100 interacts with ETS-1 and stimulates its transcriptional activity.
Molecular and cellular biology 2002;22(8):2687-702.
2001: Régine Millon; Danièle Muller; I Schultz; R Salvi; Jean-Pierre Ghnassia; T Frebourg; Bohdan Wasylyk; Joseph Abecassis
Loss of MDM2 expression in human head and neck squamous cell carcinomas and clinical significance.
Oral oncology 2001;37(8):620-31.
2001: Abdelkader Ayadi; Hong Zheng; Peter Sobieszczuk; Gilles Buchwalter; P Moerman; K Alitalo; Bohdan Wasylyk
Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1.
The EMBO journal 2001;20(18):5139-52.
2001: S Sengupta; Bohdan Wasylyk
Ligand-dependent interaction of the glucocorticoid receptor with p53 enhances their degradation by Hdm2.
Genes & development 2001;15(18):2367-80.
2001: Abdelkader Ayadi; M Suelves; Pascal Dollé; Bohdan Wasylyk
Net, an Ets ternary complex transcription factor, is expressed in sites of vasculogenesis, angiogenesis, and chondrogenesis during mouse development.
Mechanisms of development 2001;102(1-2):205-8.
2001: Manuela Argentini; N Barboule; Bohdan Wasylyk
The contribution of the acidic domain of MDM2 to p53 and MDM2 stability.
Oncogene 2001;20(11):1267-75.
2000: S Sengupta; Jean-Luc Vonesch; C Waltzinger; Hong Zheng; Bohdan Wasylyk
Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells.
The EMBO journal 2000;19(22):6051-64.
2000: C Ducret; Sauveur-Michel Maira; Yves Lutz; Bohdan Wasylyk
The ternary complex factor Net contains two distinct elements that mediate different responses to MAP kinase signalling cascades.
Oncogene 2000;19(44):5063-72.
2000: Gitali Ganguli; Joseph Abecassis; Bohdan Wasylyk
MDM2 induces hyperplasia and premalignant lesions when expressed in the basal layer of the epidermis.
The EMBO journal 2000;19(19):5135-47.
2000: Manuela Argentini; N Barboule; Bohdan Wasylyk
The contribution of the RING finger domain of MDM2 to cell cycle progression.
Oncogene 2000;19(34):3849-57.
2000: Christine Wasylyk; Bohdan Wasylyk
Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.
Molecular and cellular biology 2000;20(15):5554-70.
2000: S Sengupta; R Ralhan; Bohdan Wasylyk
Tumour regression in a ligand inducible manner mediated by a chimeric tumour suppressor derived from p53.
Oncogene 2000;19(3):337-50.
1999: C Ducret; Sauveur-Michel Maira; Andrée Dierich; Bohdan Wasylyk
The net repressor is regulated by nuclear export in response to anisomycin, UV, and heat shock.
Molecular and cellular biology 1999;19(10):7076-87.
1999: Paola Criqui-Filipe; C Ducret; Sauveur-Michel Maira; Bohdan Wasylyk
Net, a negative Ras-switchable TCF, contains a second inhibition domain, the CID, that mediates repression through interactions with CtBP and de-acetylation.
The EMBO journal 1999;18(12):3392-403.
1999: Christine Wasylyk; R Salvi; Manuela Argentini; C Dureuil; I Delumeau; Joseph Abecassis; Laurent Debussche; Bohdan Wasylyk
p53 mediated death of cells overexpressing MDM2 by an inhibitor of MDM2 interaction with p53.
Oncogene 1999;18(11):1921-34.
1999: C Giovane; Gilles Trave; A Briones; Yves Lutz; Bohdan Wasylyk; Etienne Weiss
Targetting of the N-terminal domain of the human papillomavirus type 16 E6 oncoprotein with monomeric ScFvs blocks the E6-mediated degradation of cellular p53.
Journal of molecular recognition : JMR 1999;12(2):141-52.
1999: M Alkhalaf; Gitali Ganguli; Nadia Messaddeq; Marianne Le Meur; Bohdan Wasylyk
MDM2 overexpression generates a skin phenotype in both wild type and p53 null mice.
Oncogene 1999;18(7):1419-34.
1998: Thierry Léveillard; P Gorry; Karen Niederreither; Bohdan Wasylyk
MDM2 expression during mouse embryogenesis and the requirement of p53.
Mechanisms of development 1998;74(1-2):189-93.
1998: Bohdan Wasylyk; James Hagman; Arthur Gutierrez-Hartmann
Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway.
Trends in biochemical sciences 1998;23(6):213-6.
1997: Thierry Léveillard; Bohdan Wasylyk
The MDM2 C-terminal region binds to TAFII250 and is required for MDM2 regulation of the cyclin A promoter.
The Journal of biological chemistry 1997;272(49):30651-61.
1997: L Andera; Bohdan Wasylyk
Transcription abnormalities potentiate apoptosis of normal human fibroblasts.
Molecular medicine (Cambridge, Mass.) 1997;3(12):852-63.
1997: A Giovane; Peter Sobieszczuk; Abdelkader Ayadi; Sauveur-Michel Maira; Bohdan Wasylyk
Net-b, a Ras-insensitive factor that forms ternary complexes with serum response factor on the serum response element of the fos promoter.
Molecular and cellular biology 1997;17(10):5667-78.
1997: S L Hahn; Bohdan Wasylyk; Paola Criqui-Filipe; P Criqui
Modulation of ETS-1 transcriptional activity by huUBC9, a ubiquitin-conjugating enzyme.
Oncogene 1997;15(12):1489-95.
1997: Andrew P Bradford; Christine Wasylyk; Bohdan Wasylyk; Arthur Gutierrez-Hartmann
Interaction of Ets-1 and the POU-homeodomain protein GHF-1/Pit-1 reconstitutes pituitary-specific gene expression.
Molecular and cellular biology 1997;17(3):1065-74.
1997: Christine Wasylyk; Andrew P Bradford; Arthur Gutierrez-Hartmann; Bohdan Wasylyk
Conserved mechanisms of Ras regulation of evolutionary related transcription factors, Ets1 and Pointed P2.
Oncogene 1997;14(8):899-913.
1996: Sauveur-Michel Maira; Jean-Marie Wurtz; Bohdan Wasylyk
Net (ERP/SAP2) one of the Ras-inducible TCFs, has a novel inhibitory domain with resemblance to the helix-loop-helix motif.
The EMBO journal 1996;15(21):5849-65.
1996: D Fitzsimmons; W Hodsdon; W Wheat; Sauveur-Michel Maira; Bohdan Wasylyk; James Hagman
Pax-5 (BSAP) recruits Ets proto-oncogene family proteins to form functional ternary complexes on a B-cell-specific promoter.
Genes & development 1996;10(17):2198-211.
1996: Thierry Léveillard; L Andera; N Bissonnette; L Schaeffer; L Bracco; Jean-Marc Egly; Bohdan Wasylyk
Functional interactions between p53 and the TFIIH complex are affected by tumour-associated mutations.
The EMBO journal 1996;15(7):1615-24.
1995: M C Dubs-Poterszman; B Tocque; Bohdan Wasylyk
MDM2 transformation in the absence of p53 and abrogation of the p107 G1 cell-cycle arrest.
Oncogene 1995;11(11):2445-9.
1995: A Giovane; Peter Sobieszczuk; C Mignon; M G Mattei; Bohdan Wasylyk
Locations of the ets subfamily members net, elk1, and sap1 (ELK3, ELK1, and ELK4) on three homologous regions of the mouse and human genomes.
Genomics 1995;29(3):769-72.
1995: Andrew P Bradford; K E Conrad; Christine Wasylyk; Bohdan Wasylyk; Arthur Gutierrez-Hartmann
Functional interaction of c-Ets-1 and GHF-1/Pit-1 mediates Ras activation of pituitary-specific gene expression: mapping of the essential c-Ets-1 domain.
Molecular and cellular biology 1995;15(5):2849-57.
1994: Christine Wasylyk; Sauveur-Michel Maira; Peter Sobieszczuk; Bohdan Wasylyk
Reversion of Ras transformed cells by Ets transdominant mutants.
Oncogene 1994;9(12):3665-73.
1994: S L Hahn; Bohdan Wasylyk
The oncoprotein v-Ets is less selective in DNA binding than c-Ets-1 due to the C-terminal sequence change.
Oncogene 1994;9(9):2499-512.
1994: A Giovane; A Pintzas; Sauveur-Michel Maira; Peter Sobieszczuk; Bohdan Wasylyk
Net, a new ets transcription factor that is activated by Ras.
Genes & development 1994;8(13):1502-13.
1993: P Salmon; A Giovane; Bohdan Wasylyk; David Klatzmann
Characterization of the human CD4 gene promoter: transcription from the CD4 gene core promoter is tissue-specific and is activated by Ets proteins.
Proceedings of the National Academy of Sciences of the United States of America 1993;90(16):7739-43.
1993: Christine Wasylyk; Bohdan Wasylyk
Oncogenic conversion of Ets affects redox regulation in-vivo and in-vitro.
Nucleic acids research 1993;21(3):523-9.
1993: Bohdan Wasylyk; S L Hahn; A Giovane
The Ets family of transcription factors.
European journal of biochemistry / FEBS 1993;211(1-2):7-18.
1992: Christine Wasylyk; Bohdan Wasylyk
Oncogenic conversion alters the transcriptional properties of ets.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1992;3(9):617-25.
1992: Christine Wasylyk; J P Kerckaert; Bohdan Wasylyk
A novel modulator domain of Ets transcription factors.
Genes & development 1992;6(6):965-74.
1992: J Schneikert; Y Lutz; Bohdan Wasylyk
Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family.
Oncogene 1992;7(2):249-56.
1991: A Gutman; Christine Wasylyk; Bohdan Wasylyk
Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter.
Molecular and cellular biology 1991;11(10):5381-7.
1991: Christine Wasylyk; A Gutman; R Nicholson; Bohdan Wasylyk
The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins.
The EMBO journal 1991;10(5):1127-34.
1991: J Schneikert; J L Imler; Bohdan Wasylyk
Repression by Jun of the Polyoma-virus enhancer overrides activation in a cell specific manner.
Nucleic acids research 1991;19(4):783-7.
1990: Bohdan Wasylyk; Christine Wasylyk; P Flores; A Begue; D Leprince; Dominique Stehelin
The c-ets proto-oncogenes encode transcription factors that cooperate with c-Fos and c-Jun for transcriptional activation.
Nature 1990;346(6280):191-3.
1990: Christine Wasylyk; J Schneikert; Bohdan Wasylyk
Oncogene v-jun modulates DNA replication.
Oncogene 1990;5(7):1055-8.
1990: A Gutman; Bohdan Wasylyk
The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites.
The EMBO journal 1990;9(7):2241-6.
1989: Christine Wasylyk; P Flores; A Gutman; Bohdan Wasylyk
PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes.
The EMBO journal 1989;8(11):3371-8.
1989: Christine Wasylyk; Bohdan Wasylyk; Gisela Heidecker; Mahmoud Huleihel; U R Rapp
Expression of raf oncogenes activates the PEA1 transcription factor motif.
Molecular and cellular biology 1989;9(5):2247-50.
1989: J L Imler; Bohdan Wasylyk
AP1, a composite transcription factor implicated in abnormal growth control.
Progress in growth factor research 1989;1(2):69-77.
1988: Bohdan Wasylyk; J L Imler; Bruno Chatton; C Schatz; Christine Wasylyk
Negative and positive factors determine the activity of the polyoma virus enhancer alpha domain in undifferentiated and differentiated cell types.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(21):7952-6.
1988: Christine Wasylyk; J L Imler; Bohdan Wasylyk
Transforming but not immortalizing oncogenes activate the transcription factor PEA1.
The EMBO journal 1988;7(8):2475-83.
1988: J Perez-Mutul; M Macchi; Bohdan Wasylyk
Mutational analysis of the contribution of sequence motifs within the IgH enhancer to tissue specific transcriptional activation.
Nucleic acids research 1988;16(13):6085-96.
1988: J L Imler; E Ugarte; Christine Wasylyk; Bohdan Wasylyk
v-jun is a transcriptional activator, but not in all cell-lines.
Nucleic acids research 1988;16(7):3005-12.
1988: J L Imler; C Schatz; Christine Wasylyk; Bruno Chatton; Bohdan Wasylyk
A Harvey-ras responsive transcription element is also responsive to a tumour-promoter and to serum.
Nature 1988;332(6161):275-8.
1987: J L Imler; C Lemaire; Christine Wasylyk; Bohdan Wasylyk
Negative regulation contributes to tissue specificity of the immunoglobulin heavy-chain enhancer.
Molecular and cellular biology 1987;7(7):2558-67.
1987: Christine Wasylyk; J L Imler; J Perez-Mutul; Bohdan Wasylyk
The c-Ha-ras oncogene and a tumor promoter activate the polyoma virus enhancer.
Cell 1987;48(3):525-34.
1986: P Gerlinger; Marianne LeMeur; C Irrmann; P Renard; Christine Wasylyk; Bohdan Wasylyk
B-lymphocyte targeting of gene expression in transgenic mice with the immunoglobulin heavy-chain enhancer.
Nucleic acids research 1986;14(16):6565-77.
1986: E Borrelli; R Hen; Christine Wasylyk; Bohdan Wasylyk; P Chambon
The immunoglobulin heavy chain enhancer is stimulated by the adenovirus type 2 E1A products in mouse fibroblasts.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(9):2846-9.
1986: Christine Wasylyk; Bohdan Wasylyk
The immunoglobulin heavy-chain B-lymphocyte enhancer efficiently stimulates transcription in non-lymphoid cells.
The EMBO journal 1986;5(3):553-60.
1984: P Augereau; Bohdan Wasylyk
The MLV and SV40 enhancers have a similar pattern of transcriptional activation.
Nucleic acids research 1984;12(23):8801-18.
1984: Bohdan Wasylyk; Christine Wasylyk; P Chambon
Short and long range activation by the SV40 enhancer.
Nucleic acids research 1984;12(14):5589-608.
1984: Bohdan Wasylyk; Christine Wasylyk; P Chambon
A novel eukaryotic promoter element: the simian virus 40 72 base pair repeat.
Federation proceedings 1984;43(2):226-34.
1983: Bohdan Wasylyk; Christine Wasylyk; P Augereau; P Chambon
The SV40 72 bp repeat preferentially potentiates transcription starting from proximal natural or substitute promoter elements.
Cell 1983;32(2):503-14.
1983: Bohdan Wasylyk; Christine Wasylyk; H Matthes; M Wintzerith; Pierre Chambon
Transcription from the SV40 early-early and late-early overlapping promoters in the absence of DNA replication.
The EMBO journal 1983;2(9):1605-11.
1982: Bohdan Wasylyk; M P Gaub; Andrée Dierich; Christine Wasylyk; P Chambon
The conalbumin "TATA" box sequence and the SV40 72 base-pair repeat region influence expression of a chimeric gene in vivo.
Progress in clinical and biological research 1982;85 Pt A():13-24.
1981: P Moreau; R Hen; Bohdan Wasylyk; R Everett; M P Gaub; P Chambon
The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants.
Nucleic acids research 1981;9(22):6047-68.